In November 2016, pharmaceutical company Takeda is planning to revamp its strategy by pairing up with few other companies to carry on clinical trials, analyse data and make biosensor and wearable technology. The company has embraced the platform of Koneska Health, a company that works with data collected with the help of mobile, wearable and other technologies to monitor health indicators to uplift the companys process of conducting clinical trials by using biosensors and wearables. The ultimate goal of the company is to develop digital biomarkers- data or information that is collected from devices that monitor the vital signs, sleep patterns and activity levels of patients. Takeda hopes that eventually these metrics will assist in making decisions and establish endpoints to track a patients health in a daily setting. Takeda is also looking to collaborate with an image analysis and data company, Definiens which is based in Germany for other areas of clinical trials i.e. tissue analysis. By using the cloud-based digital pathology platform VeriTrova developed by Definiens, Takeda will make use of the technology to reduce the analysis time from months to weeks. The cloud-based digital pathology platform also enables biomarker analysis. Thomas Colarusso, Vice President of Business Development Strategy, Definiens, said that VeriTrova helps in accelerating clinical trials with remote uploading and viewing of digitized IHC images from lab partners and CROs to the cloud where analysis of the image takes place.SYMPTOMS & TREATMENTS OF A HEART ATTACK
On November 21, 2016, Pathcore and Visiopharm announced that both the companies will join hands to offer an improved workflow software solutions for the quantitative analysis and the management of digital pathology images. The joint venture binds together a wide range of image analysis and management tools that improves productivity, collaboration and reporting abilities. Pathcores integrated solutions is apt for customers looking for a quantitative analysis in their workflow owing to the state-of-the-art system for archiving images, managing metadata, publishing reports, drawing annotations, searching data and exporting content. The partnership with Pathcore opens new avenues and opportunities for Visiopharm to get closer to its strategic goal to continuously enhance their digital pathology workflow. It also creates new opportunities to integrate medical imaging results across various disciplines to offer an overview of each patient. A recent report that studies the digital pathology market published by Progressive Markets offers useful insights such as the market share, size and growth.